Companies / Mineralys Therapeutics Inc

Mineralys Therapeutics Inc

Nasdaq: MLYSCIK 1933414RADNOR, PA

Financials

Revenue—
Net income$-154.65M
Total debt$100.0K
Cash$138.27M
Diluted EPS$-2.29
Shares outstanding88.4M

Ownership

88.4M shares outstanding · as of Aug 3, 2026
16.6%Insiders
Ownership
Insiders16.60%14,671,288
10%+ / strategic10.33%9,131,166
Institutions82.49%72,929,881
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 15

View all →
Insider% of sharesShares
Slingsby Brian TaylorDirector · 10% owner
8.95%7,910,038
RA Capital Management, L.P.Director
6.59%5,825,521
Congleton JonCEOChief Executive Officer · Director
0.88%780,051
Rodman David MalcomChief Medical Officer
0.09%76,140
Levy Adam ScottCFO and Secretary
0.05%48,538
Akkaraju SrinivasDirector · 10% owner
<0.01%6,200
DiRocco DerekDirector
<0.01%6,200
Gold Alexander MDirector
<0.01%6,200
Karydas DaphneDirector
<0.01%6,200
Sblendorio GlennDirector
<0.01%6,200

Institutional holders 227

View all →
HolderValue% of shares
Catalys Pacific, LLC$286.83M8.94%
Samsara BioCapital, LLC$213.06M6.64%
RA Capital Management, L.P.$208.40M8.70%
Fmr LLC$183.54M5.72%
BlackRock, Inc.$158.83M6.66%
Vanguard Group Inc$121.68M3.79%
State Street Corporation$111.74M4.68%
Caligan Partners LP$100.62M3.14%
Franklin Resources, Inc.$64.91M2.02%
Laurion Capital Management LP$60.47M2.52%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 27, 2026RA Capital Management, L.P.
Director
BuyCommon Stock$7.35M+311K
+5.69%
5,767,221
6.52% of shares
high
Jan 5, 2026Rodman David Malcom
Executive
SellCommon Stock$4.85M-139K
-54.71%
115,274
0.13% of shares
medium
Jan 2, 2026Rodman David Malcom
Executive
SellCommon Stock$2.51M-70K
-50.30%
69,188
0.08% of shares
medium
Jan 5, 2026Rodman David Malcom
Executive
SellCommon Stock$1.90M-53K
-46.39%
61,804
0.07% of shares
medium
Mar 30, 2026RA Capital Management, L.P.
Director
BuyCommon Stock$1.41M+58K
+1.01%
5,825,521
6.59% of shares
high
Jan 5, 2026Rodman David Malcom
Executive
ExerciseCommon Stock$961.5K+67K
+36.07%
254,519
0.29% of shares
low
Jan 5, 2026Rodman David Malcom
Executive
ExerciseCommon Stock$858.1K+54K
+40.20%
187,046
0.21% of shares
low
Jan 14, 2026Rodman David Malcom
Executive
SellCommon Stock$370.6K-11K
-18.39%
50,437
0.06% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Catalys Pacific Fund, LPPassive13G/A———
BlackRock, Inc.Passive13G—4,113,657—
Fmr LLCPassive13G—5,017,509—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MLYSCommon StockEquity603170101BBG00ZXN1GN3